Skip to content
PICO Portalanswers from OpenAlex

Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases

PaperCitations, authors & open-access status

Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases is a paper indexed in PICO Portal from OpenAlex.

How many citations does Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases have?

PICO Portalcitation count

Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases has 83 citations in the OpenAlex counts PICO Portal stores.

When was Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases published?

PICO Portalyear

Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases has 2016 year in the PICO Portal index.

What is the open-access status of Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases?

PICO Portaloa status

Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases has gold oa status in the PICO Portal index.

What is the DOI of Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases?

PICO Portaldoi

The DOI for Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases is on the source record.

What is the PMID of Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases?

PICO Portalpmid

The PMID for Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases is on the source record.

What is the OpenAlex record for Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases?

PICO Portalopenalex

The OpenAlex for Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial